ResMed | RMD - Equity Capital And Reserves

Stock Price
227.88
Daily Change
-5.62 -2.41%
Monthly
-11.09%
Yearly
2.63%
Q1 Forecast
223.87

ResMed reported $6.32B in Equity Capital and Reserves for its fiscal quarter ending in December of 2025.





Equity Capital And Reserves Change Date
Ansell USD 1.97B 10.2M Dec/2025
Artivion USD 448.23M 9.54M Dec/2025
AtriCure USD 491.94M 15.43M Dec/2025
Baxter International USD 6.13B 1.11B Dec/2025
Cochlear AUD 1.94B 12.2M Dec/2025
Cooper Companies USD 8.36B 124.7M Dec/2025
CSL USD 18.66B 2.75B Dec/2025
Dexcom USD 2.75B 19.9M Dec/2025
Edwards Lifesciences USD 10.2B 340.3M Sep/2025
Fisher Paykel Healthcare NZD 1.99B 95.8M Dec/2025
Globus Medical USD 4.57B 174.42M Dec/2025
Haemonetics USD 911.45M 62.28M Dec/2025
Hologic USD 5.25B 197.2M Dec/2025
Idexx Laboratories USD 1.61B 44.2M Dec/2025
Inogen USD 197.18M 2.32M Sep/2025
Insulet USD 1.52B 131.1M Dec/2025
Integra LifeSciences USD 1.04B 5.89M Dec/2025
Intuitive Surgical USD 17.82B 894.3M Dec/2025
Masimo USD 721.2M 88.8M Dec/2025
Medtronic USD 48.86B 964M Sep/2025
Philips EUR 10.58B 204M Sep/2025
Ramsay Health Care AUD 4.79B 916.1M Dec/2025
ResMed USD 6.32B 199.61M Dec/2025
Sigma Healthcare AUD 4.67B 3.8B Dec/2025
Sonic Healthcare AUD 8.2B 120.9M Dec/2024
Steris USD 7.15B 145.4M Dec/2025
Teleflex USD 3.12B 697.09M Dec/2025
Thermo Fisher Scientific USD 53.54B 2.38B Dec/2025